The respective mean 24 h urinary excretions of sulphoconjugated 16\ g=a\ \ x=r eq-\ hydroxydehydroepiandrosterone, 16-oxo-androstenediol, and dehydroepiandrosterone were found to be 1040, 230, and 668 \g=m\g/24 h for normal males, and 621, 209, and 304 \g=m\g/24 h for normal non-pregnant females.
16\g=a\-hydroxydehydroepiandrosterone sulphate and oestriol in normal pregnancy.
The results are considered to be consistent with a limited transplacental passage of neutral steroids from the foetoplacental to maternal circulation.
It is well recognised that in late pregnancy, dehydroe/?zandrosterone and 16a-hydroxydehydro<?/?¿androsterone of foetal origin are quantitatively important precursors of the considerable amount of oestriol excreted in the maternal urine (for review see Diczfalusy 1969) .
Although the placenta can be regarded as a barrier preventing the passage of androgens from the foetal to maternal circulations (Diczfalusy 1964) , there is evidence for the transplancental passage of dehydroe/«'androsterone sulphate (Siiteri 8c MacDonald 1967) , 16a-hydroxydehydroepiandrosterone sulphate (Younglai 8c Solomon 19676) and 16-oxo-androstenediol (Reynolds et al. 1968) from the foetoplacental to maternal circulations.
It was of interest therefore to determine whether increasing amounts of these neutral steroid sulphates were excreted in the urine during normal pregnancy. An increased excretion of 16a-hydroxydehydroe/nandrosterone sulphate and decreased excretion of dehydro£?/»zandrosterone sulphate has been reported in normal pregnancy near term compared with excretions by non-pregnant females (LeRoy Heinrichs 8c Colas 1965) .
This report presents data on the excretion of sulphoconjugated dehydroe/)iandrosterone, 16a-hydroxydehydro<?/>iandrosterone and 16-oxo-androstenediol by normal pregnant females between the 10th week of gestation and term, and by non-pregnant females and endocrinologically normal males.
EXPERIMENTAL
Subjects and urine collections 24 hour urine collections were obtained from 9 normal males, 10 normal nonpregnant females, and 22 normal pregnant females between the 10th week of gestation and term. All the pregnant subjects were receiving antenatal care, and all delivered a healthy infant at term after a pregnancy free from any significant complication. Urine samples were stored without preservative at -20°C pending analysis.
Abbreviations and trivial names D, dehydroe^iandrosterone (3/?-hydroxy-androst-5-en-17-one), 16a-HO-D, 16a-hydroxydehydroe/uandrosterone (3/?,16a-dihydroxy-androst-5-en-l7-one), 16-oxo-A, 16-oxo-androstenediol (3/?,17/?-dihydroxyandrost-5-en-16-one Horning (1968) , except that for silanisation a 1°/o solution of dimethyldichloro silane was used.
Gas chromatography was carried out on any one of the three columns shown in Table 1 below. With the amplifier set to give a full scale deflection of 1 X 10-10 A, 2-5 µ aliquots of both samples and standards were injected. The TMS ethers of 16a-HO-D, 16-oxo-A and D were identified by their retention times relative to the internal standard, and quantitated from the area of the steroid TMS ether peak relative to the internal standard peak.
Validation of the method Specificity Fig. 1 shows chromatograms of the C-16 oxygenated steroid fraction from preg¬ nancy urine on QF-1, XE-60, and HI-EFF columns. The agreement between relative retention times for the peaks from standard steroid and from the extract on each phase (Table 1) provided some evidence of specificity. Quantitative data obtained on the three columns from urines from both pregnant and non-pregnant individuals also showed good agreement.
More definitive information on specificity was obtained by mass spectrometry of the steroid TMS ethers trapped from the effluent of the analytical GLC column.
A pool of late pregnancy urine was processed for C-16 oxygenated steroid and D sulphates by the above procedure. Gas chromatography of each fraction was carried Although the mean excretion of each steroid was higher in males than in females, statistical significance of the differences could not be firmly estab- Table 5 shows the excretions of the neutral steroid sulphates, oestriol and pregnanediol by normal pregnant females between the 10th and 40th week of gestation.
The data were grouped into periods of ten or five weeks, and for each period, the mean and standard deviation for the excretions of the neutral steroid sulphates were calculated using logarithms of the excretions and assuming a log normal distribution of values. Fig. 5 The data on steroid excretion at the different stages of pregnancy were therefore combined to give a pooled estimate of the excretions of 16a-HO-DS, (Jänne & Vihko 1969) , and have been identified and quantitated as their disulphates in pregnancy urine (Jänne 8c Vihko 1970a (Sjövall 1970 (Younglai 8c Solomon 19676) and DS (Siiteri 8c MacDonald 1967) also suggest that the ex¬ tent of this transfer might be limited.
The absence of any apparent relationship between the excretions of 16a-HO-DS and oestriol is somewhat surprising in view of the role of 16a-HO-DS in the foetoplacental circulation as an oestrogen precursor. 16a-HO-DS in¬ jected into the maternal circulation during the 3rd trimester can also serve as a precursor for urinary oestriol (Younglai 8c Solomon 1968) . That the ex¬ cretions of 16a-HO-DS and oestriol do not appear to be related may indicate that there is no simple relationship between the rate of placental oestriol pro¬ duction and placental 16a-HO-DS transfer.
If the pattern of excretion of DS, 16«-HO-DS and 16-oxo-AS during pregnancy does reflect the transplacental passage of neutral steroid sulphates from the foetoplacental circulation, quantitation of these steroids might be of value in providing information on foetoplacental condition in complicated pregnancies. Investigations carried out to test this possibility will be the sub¬ ject of a separate publication.
